Chemical Structure (Duloxetine 01)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 63187-735
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 63187-735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Duloxetine 02)
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
The text provides a graph showing the percentage of patients who improved with a particular medication compared to a placebo. The medication being tested is CYM60 mg taken once daily. The graph also shows the percentage of pain improvement from baseline, measured using the BOCF method. The text indicates that 100% of patients using CYM60 mg had improvement, while the placebo group had a lower percentage of improvement. The graph also shows varying levels of improvement between 80% and 50%.*
Figure 5 (Duloxetine 06)
This is a chart reporting the percentage of patients who improved their pain levels using a placebo versus CYM60/120 mg once daily. The improvement in pain is measured on the x-axis and ranges from 10% to 100%. The y-axis shows the percentage of patients improved, ranging from 0 to 100%.*
63187-735-30 (Duloxetine 09)
This text seems to describe a medication called Duloxetine, which comes in the form of 30 delayed-release capsules, each containing 60mg of the drug. The packet includes a Mastcaton Gude separately. The product ID is PDO73530. The rest of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
